WC Bioscience Accelerator Participants

Nervosave Therapeutics
Technologies
Therapeutic
Indication
Autoimmune & Inflammation
Central Nervous System Disorders
Clinical Research
Clinical Trials
Metabolic Disease
Neurodegenerative Disease
Obesity
Orphan Diseases
Executive Summary
View/DownloadWebsite
nervosavetx.comCathy Beaumard
Nervosave is an early-stage biotech company incorporated in Montpellier, France & New York, USA, with a focus on the prevention and cure of myelin-related disorders.